Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis

Completed

Conditions studied: Multiple Sclerosis

In brief

The purpose of this study is to evaluate the coorelation between patient factors, health care provider factors, drug factors and compliance in patients with relapsing forms of multiple sclerosis (RMS) treated with Disease Modifying Agents (DMA). We hypothesize that a number of factors influence compliance with DMA's.

Key facts

Study ID

NCT00223457

Run by

University of Texas Southwestern Medical Center

People needed

1040

Starts

2004-04-01

Expected to finish

2005-09-01

Last updated by the study team

2007-01-25

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of relapsing form of multiple sclerosis
• Age 18 or older
• Therapy with disease modifying agent (Glatiramer acetate, Interferon Beta-1b, ot Interferon Beta 1a (IM or SC) for at least 6 months
• Access to the internet to complete the study survey

You may not qualify if…

• Diagnosis of progressive forms of multiple sclerosis
• Therapy on DMA for less than 6 months
• Inability to complete the survey
• Participation in other investigational studies within the last 6 months

Where it is running

• UT Southwestern Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.